A recent study shows that angiotensin II receptor type 2 is expressed and localized with angiotensin II to mitochondrial inner membrane in various cell types and regulates NO generation and mitochondrial functions. The findings might have important implications in various inflammatory conditions and cell senescence.
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The renin-angiotensin system (RAS) is a dominant regulator of the cardiovascular and renal function. Ang II is the key effector molecule of this system. Most studies have focused on the effect of extracellular Ang II on its receptors on the plasma membrane. However, Ang II and renin are also co-localized intracellularly in many types of cells including juxtaglomerular cells, 3 cultured neuroblastoma, 4, 5 and various endocrine cells. Intracellular Ang II is generated within the cells and secreted for local paracrine function. It is also transported from the extracellular space via an intracrine mechanism. Induction of Ang II expression in stretched cardiac myocyte and consequent myocyte hypertrophy may represent an intracrine mechanism. 6 Likewise, microinjection of Ang II in vascular smooth muscle cells results in an increase in [Ca 2ϩ ]i via intracellular AT 1 . 7 Neonatal cardiac myocytes transfected with an adenoviral Ang II expression vector shows elevated rate of cellular hypertrophy independent of cell surface AT 1. 8 Adult mice injected with an Ang II expression plasmid vector develop significant cardiac hypertrophy without an increase in blood pressure or plasma Ang II levels. 7 These effects were not suppressed by losartan administration indicating an intracellular mechanism of the intracrine Ang II. 9 These observations suggest possible functions of intracellular Ang II via intracellular AT 1 if Ang II gains access to the intracellular space either by internalization or possibly by local biosynthesis. The presence of AT 2 also has been reported in the nucleus of sheep kidney cortical cells, which is functionally linked to endothelial nitric oxide synthetase (eNOS) and soluble guanylyl cyclase. 10 AT 2 on plasma membrane could also stimulate NO synthesis with or without the bradykinin B 2 receptor participation. [11] [12] [13] The studies discussed above have suggested the presence of an intracellaular RAS. Likewise, previous studies have implicated biological effects of Ang II in mitochondrial size and proliferation. However, the presence of mitochondrial angiotensin system had remained unrecognized until a recent report by Abadir et al. 1 These investigators showed that Ang II and its receptor AT 2 co-localize on mitochondrial inner membrane in a variety of human and mouse tissues including human skeletal muscle cells, monocytes, mouse cardiac myocytes, renal tubular cells, neuronal cells, vascular endothelial cells, and hepatocytes by immunogold electron microscopy. Mitochondrial localization of AT 2 was further confirmed by fluorescence overlay in human fibroblast transfected with AT 2 -green fluorescent protein fusion protein and fluorescence labeling of mitochondria by MITO Tracker Red. These findings suggest that Ang II and AT 2 may be common general components of the inner membrane of the mitochondria. An interesting observation was that AT 2 expression in the mitochondria of mouse renal tubular cells was decreased with age. In contrast, type 1 Ang II receptor AT 1 level, which is very low in mitochondria of young mice, was markedly elevated with age (70 wk of age). Long-term treatment of animals with the AT 1 receptor blocker losartan maintained the mitochondrial (mt) AT 2 at a high level in aged animals, whereas the elevated AT 1 in aged animals was not affected by losartan.
Functionally, stimulation of isolated mitochondria by the AT 2 -specific agonist CGP421140 resulted in a dosedependent increase in nitric oxide (NO) production. Respiratory oxygen consumption by the isolated mitochondria with glutamate/malate-ADP-support was suppressed by NO produced by CGP stimulation, but the suppression of respiration was reversed by the inhibition of NO synthetase (NOS) by AT 2 specific antagonist PD123319 or by NOS inhibitor L-nitroarginine methyl ester. Inhibition of respiration by CGP was not accompanied by changes in the membrane potential indicating that the bioenergetic properties of the mitochondria were not affected. The suppression of respiration by NO was presumably due to its competition with O 2 for binding to cytochrome C oxidase (COX IV), which is also located in the inner membrane of the mitochondria. These observations clearly demonstrate intra mitochondrial localization and function of AT 2 and its role in activating mtNOS to produce NO and inhibit respiration. The inverse relationship between intramitochondrial levels of AT 1 and AT 2 with aging is particularly intriguing. The tissue protective NO production mediated by mtAT 2 -mtNOS decreased with aging and harmful reactive oxygen species producing mtAT 1 increased in 70-wk-old mice. Long-term administration of AT 1 The studies by Abadir et al. 1 connect the discovery of intra-mitochondrial presence of Ang II type 2 receptor AT 2 , to aging mtNOS. It is likely that increased NO in mitochondria would suppress O 2 consumption and presumably ROS generation as summarized in Figure. The discovery of intra mitochondrial AT 1 and AT 2 and age-dependent changes in their levels provides new insights into the mechanisms that contribute to senescence. AT 1 disrupted mice exhibited a 36% prolongation of life span associated with an increase in the number of mitochondria and upregulation of prosurvival genes for nicotinamide phosphoribosyl transferase and sirtuin 3 in the kidney. In cultured tubular epithelial cells Ang II downregulated sirtuin 3 mRNA, which was reversed by AT 1 antagonist. 2 Resveratrol, a polyphenol found in red wine, is known to activate sirtuin 1, a longevity gene and suppresses AT 1 in vascular smooth muscle cells. The AT 1 suppression is considered to contribute to the longevity of vascular smooth muscle cells. Given the preservation of high mitochondrial level of AT 2 by AT 1 blocker, it raises the important question whether high mitochondrial AT 2 or suppression of AT 1 level is causally related longevity.
The mechanisms by which the components of RAS, which are expressed from genomic DNA outside the mitochondria, are transported into inner mitochondria remain unknown. Mitochondria are known to contain NOS (mtNOS) in the inner membrane, which generates NO constitutively when the mitochondria are energized by succinate. The basal NOS activity is maintained by endogenous Ca 2ϩ in the mitochondria. Increased mitochondrial Ca 2ϩ levels markedly elevate NOS activity. 14 Technically, the use of a specific AT 2 agonist instead of use of dual (for AT 1 and AT 2 ) agonist Ang II facilitated the discovery of unique functions of AT 2 . It is encouraging that a variety of AT 2 specific agonists are becoming available as a combination of AT 2 agonist and AT 1 blocker may have a greater therapeutic effect than AT 1 antagonist alone. Such a specific agonist will be equally beneficial for therapeutic purposes. Be that as it may, the discovery of the presence of Ang II and AT 2 and AT 1 inside mitochondrion, and their regulatory functions on NO generation and respiration related to generation of reactive oxygen species, will allow us powerful tools for studying the mechanism of inflammatory tissue damage and senescence.
Figure.
High level of No⅐ production by mitochondrial AT 2 is markedly reduced by aging. The aging increases mtAT 1 (shown in gray). Long-term blockade of AT 1 by an AT 1 blocker prevents the harmful effects of aging (shown in black). 1 
